T cell stemness and dysfunction in tumors are triggered by a common mechanism
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Stemness against adversity T lymphocytes are powerful immune cells that can destroy tumors, but cancers have developed tricks to evade killing. Vodnala et al. found that potassium ions in the tumor microenvironment serve a dual role of influencing T cell effector function and stemness (see the Perspective by Baixauli Celda et al. ). Increased potassium impairs T cell metabolism and nutrient uptake, resulting in a starvation state known as autophagy. The increased potassium can also preserve T cells in a stem-like state where they retain the capacity to divide. These seemingly divergent processes are linked to the cellular distribution of acetyl–coenzyme A, which, when manipulated, can restore the ability of human T cells to eliminate tumors in mice. Science , this issue p. eaau0135 ; see also p. 1395
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disabled autophagy due to progressive depletion of spermidine in aging tissues 233 can be expected to interfere with the immune recognition of cancer cells due the incapacity of dendritic cells to recognize autophagy-deficient cancer cells, as well as due to defective T lymphocyte and NK cell responses.163,252”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
Experimental — accuracy not yet measuredIn the citing paper
“This relies on cancer cell-autonomous effects but may also involve the autophagy-driven maintenance of a functional T cell memory stem cell pool, hence avoiding the exhaustion of the anticancer immune response.163”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [163]
In the citing paper
“In addition, the extracellular release of potassium by dying cancer cells leads to the induction of autophagy in CD8+ T cells, thus resulting in the acquisition of a stem cell‐like phenotype and ultimately improving tumor clearance.”
From Autophagy in major human diseases (2021) · cites this paper as Vodnala et al, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823 · cited 2×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationAdoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506 · cited 1×
“Nonetheless, the T cells of some patients maintain the capacity to proliferate, persist, and mediate the complete destruction of large tumor deposits (1).”
BackgroundSelf-citationRosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,140 · cited 1×
“For example, TILs can be expanded ex vivo (>10(10) cells) and readministered to cancer patients, resulting in clonal repopulation and the durable destruction of large metastatic solid tumors (2, 3).”
BackgroundSelf-citationDefining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Im, S. J., Hashimoto, M., Gerner, M. Y., Lee, J., Kissick, H. T., Burger, M. C., Shan, Q., Hale, J. S., Lee, J., Nasti, T. H., et al. (2016) · Nature · doi:10.1038/nature19330 · Cited by 2,070 · cited 1×
“GSEA revealed that ↑[K]e conditioning resulted in a transcriptional profile that parallels the subset of CD8 T cells recently identified as retaining stemness and the capacity to respond to PD-1 therapy in the setting of chronic antigen exposure (15) (Fig.”
BackgroundDefining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053 · cited 6×
“We and others have previously identified the transcription factor Tcf7 as being critically involved in the retention of stemcell–like attributes in antigen-experienced T cells (9, 11).”
BackgroundInfluential
Research works printed but not linked: 1
- Lodish H, Berk A, Zipursky S, in Molecular Cell Biology, 4th Edition (2000), pp. 1– 5.
Cited by
Items 301–400 of 559
Nguyen, L. N., Nguyen, L. N. T., Zhao, J., Schank, M., Dang, X., Cao, D., Khanal, S., Thakuri, B. K. C., Zhang, J., Lu, Z., et al. (2021) · Hepatology · doi:10.1002/hep.32008 · Cited by 18
Liu, Y., Wang, T., Ma, W., Jia, Z., Wang, Q., Zhang, M., Luo, Y., & Sun, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1327717 · Cited by 18
Stratifying nutritional restriction in cancer therapy: Next stop, personalized medicine
Krstić, J., Pieber, T. R., & Prokesch, A. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.03.001 · Cited by 19
Next Generation Imaging Techniques to Define Immune Topographies in Solid Tumors
Pietrobon, V., Cesano, A., Marincola, F. M., & Kather, J. N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.604967 · Cited by 20
Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
Fan, C., Kam, S., & Ramadori, P. (2021) · Cancers · doi:10.3390/cancers13205250 · Cited by 21
Bhlhe40 Keeps Resident T Cells Too Fit to Quit
Park, S. L., & Mackay, L. K. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.016 · Cited by 18
Chromium Nanoparticles Improve Macrophage and T Cell Infiltration for Cancer Immunotherapy
Liu, Q., Sun, Z., Duo, Y., Yin, L., Lv, K., Yue, L., Meng, Q., Nie, D., Chen, J., Luo, D., et al. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c01136 · Cited by 17
Microbiota configuration determines nutritional immune optimization
Han, S., Stacy, A., Corral, D., Link, V. M., Siqueira, M. K. D., Chi, L., Teijeiro, A., Yong, D., Pérez‐Chaparro, P. J., Bouladoux, N. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304905120 · Cited by 17
“Acetate has been shown to promote T cell responses by regulating gene expression, metabolism, and enzyme function (43–46).”
BackgroundYang, Z., Liu, L., Zhu, Z., Hu, Z., Liu, B., Gong, J., Jin, Y., Luo, J., Deng, Y., Jin, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202304501 · Cited by 18
Dong, W., Moon, S. J., Kelleher, J. K., & Stephanopoulos, G. N. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b05154 · Cited by 19
Vardeu, A., Davis, C., McDonald, I., Stahlberg, G., Thapa, B., Piotrowska, K., Marshall, M. A., Evans, T. G., Wheeler, V., Sebastian, S., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005398 · Cited by 17
“An assessment of homology between human and mouse PAP, STEAP and 5T4 proteins indicated identity of 81%, 82% and 82% and similarity of 88%, 90% and 89% at the amino acid sequence level, respectively.”
Sun, Y. H., Shao, C., Duan, H., Wang, Z., Xu, S., Wang, C., Xiu, J., Liu, J., Wang, X., Yao, X., et al. (2025) · MedComm · doi:10.1002/mco2.70496 · Cited by 20
The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
Hunt, E. G., Andrews, A. M., Larsen, S. R., & Thaxton, J. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.867341 · Cited by 18
“K-treated T cells were autophagy enriched and represented a pool of T cells with potent cytotoxicity and persistence in the TME that produced tumor clearance (Vodnala et al., 2019).”
BackgroundYang, Y., Sun, L., Chen, Z., Liu, W., Xu, Q., Liu, F., Ma, M., Chen, Y., Lü, Y., Fang, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1033497 · Cited by 18
Bai, Y., Zhang, W., Hao, L., Zhao, Y., Tsai, I.-C., Qi, Y., & Xu, Q. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112124 · Cited by 17
Zhao, Y., Qin, C., Chen, L., Li, Z., Zhao, B., Li, T., Zhang, X., & Wang, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189183 · Cited by 16
Van, N. T. H., & Nam, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116573 · Cited by 18
Legscha, K. J., Ferreira, E. A., Chamoun, A., Lang, A., Awwad, M. H. S., Ton, G. N. H. Q., Galetzka, D., Guezguez, B., Hundemer, M., Bourdon, J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001846 · Cited by 19
Stem-like T cells and niches: Implications in human health and disease
Yi, L., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907172 · Cited by 17
Caloric restriction promotes the stemness and antitumor activity of T lymphocytes
Pietrocola, F., & Kroemer, G. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1616153 · Cited by 15
“methylation of the repressive histone mark H3K27me3 in correspondence of stemness-associated loci.(6) To extend the relevance of these findings to preclinical set-”
BackgroundInfluentialZhong, B., Wang, Y., Liao, Y., Liang, J., Wang, K., Zhou, D., Zhao, Y., & Jiang, N. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01830-8 · Cited by 15
“Previous research has shown that necroptosis signaling pathways play a role in the immunosuppressive microenvironment of tumors in diseases such as pancreatic ductal adenocarcinoma (PDAC) and melanoma, leading to immune tolerance and resistance to immunotherapy [10, 11, 21].”
BackgroundKirchmair, A., Nemati, N., Lamberti, G., Trefny, M. P., Krogsdam, A., Siller, A., Hörtnagl, P., Schumacher, P., Sopper, S., Sandbichler, A. M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1267816 · Cited by 16
“Samples were stored at -80°C for 24 h, centrifuged at 1500 rpm for 15 min at 4°C and 250 µL of metabolite-containing supernatants of each sample were sent for analysis.”
MethodLi, Q., Wang, L., Xie, W., Tan, Q., Zhou, S., Pei, H., Zhang, H., Li, J., Qu, F., & Tan, W. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202505223 · Cited by 15
Prognostic Biomarkers for Melanoma Immunotherapy
Twitty, C., Huppert, L. A., & DAUD, A. I. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-0886-z · Cited by 16
Seeking Cellular Fitness and Immune Evasion: Autophagy in Pancreatic Carcinoma
Kroemer, G., & Zitvogel, L. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.05.009 · Cited by 15
Harnessing the Membrane Potential to Combat Cancer Progression
Yang, M., & Brackenbury, W. J. (2022) · Bioelectricity · doi:10.1089/bioe.2022.0001 · Cited by 15
“22”
A new dawn in the late stage of alveolar echinococcosis “parasite cancer”
Xu, K., & Ahan, A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109735 · Cited by 15
Why do platelets express K+ channels?
Wright, J. R., & Mahaut‐Smith, M. P. (2021) · Platelets · doi:10.1080/09537104.2021.1904135 · Cited by 16
CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response
Wang, Y., Hu, W., Xia, R., Yang, X., Gu, Y., Ning, Z., Yang, T., Yu, C., Zhang, L., Li, D., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.042 · Cited by 14
Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives
Wang, Z., Li, B., Tang, P., Yan, F., Wang, S., Leng, G., Dawa, P., Chen, Y., Guo, Y., Yang, P., et al. (2026) · MedComm – Oncology · doi:10.1002/mog2.70068 · Cited by 18
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity
Zhang, S., Zhang, X., Yang, H., Liang, T., & Bai, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189022 · Cited by 15
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
Nagree, M. S., Felizardo, T. C., Faber, M. L., Rybová, J., Rupar, C. A., Foley, S. R., Fuller, M., Fowler, D. H., & Medin, J. A. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114297 · Cited by 15
“Further optimization, or inclusion of elements such as cell surface markers (Wang et al, 2011; Scaife et al, 2013) or those that confer drug resistance (Jonnalagadda et al, 2013) may improve efficacy of TRaMs.”
BackgroundThe Road Less Taken: Less Appreciated Pathways for Manipulating CD8+ T Cell Exhaustion
Pichler, A., Cannons, J. L., & Schwartzberg, P. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.926714 · Cited by 14
Liu, X., Hong, R., Du, P., Yang, D., He, M., Wu, Q., Li, L., Wang, Y., Chen, J., Min, Q., et al. (2022) · Theranostics · doi:10.7150/thno.70814 · Cited by 21
Self-citationKang, Y., Zhou, B., Yuan, M., Xue, Y., Li, R., Fan, Y., Ye, J., Pei, Z., Wang, X., & Ji, X. (2025) · Cell Biomaterials · doi:10.1016/j.celbio.2025.100091 · Cited by 14
“Dissecting the role of T cell exhaustion in cancer progression: a multifaceted approach“
Li, X., & Song, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1646292 · Cited by 13
Moraly, J., Kondo, T., Benzaoui, M., DuSold, J., Talluri, S., Pouzolles, M., Chien, C. D., Dardalhon, V., & Taylor, N. N. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13691 · Cited by 13
Yang, Z., Shao, X., Wu, Y., Roy, A., García, E., Farrell, A., Pradhan, S., Guo, W., Gan, H., Korkmaz, Z., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c03781 · Cited by 14
Targeting myeloid cell immunometabolism to improve current non-small cell lung cancer therapies
Runtsch, M. C., Angiari, S., & Kargl, J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108893 · Cited by 13
Cancer genes disfavoring T cell immunity identified via integrated systems approach
Kishton, R. J., Patel, S. J., Decker, A. E., Vodnala, S. K., Cam, M., Yamamoto, T. N., Patel, Y. K., Sukumar, M., Yu, Z., Ji, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111153 · Cited by 13
“Multiple factors determine the efficacy of T cell-based cancer therapies, including features of antitumor T cells (Kishton et al., 2017; Vodnala et al., 2019) and the presence of inhibitory factors in the tumor microenvironment (Facciabene et al.”
BackgroundSelf-citationKarpathiou, G., Dridi, M., Krebs-Drouot, L., Vassal, F., Jouanneau, E., Jacquesson, T., Barrey, C. Y., Prades, J. M., Dumollard, J. M., Meyronet, D., et al. (2021) · Cancers · doi:10.3390/cancers13092169 · Cited by 13
“However, recent evidence suggests that autophagy is actively implicated in tumor infiltrating lymphocyte activity, and when T cells live inside tumors with elevated extracellular potassium, this reduces the uptake of local nutrients by these lymphocytes, leading to activation of their autophagy [14].”
BackgroundInfluentialCrosslinked PVA electrospinning nanofibrous film as a new platform for the design of K+ sensor
Shen, M., Liu, H., Pan, T., Ning, J., Zhou, D., Song, G., Wang, Y., Cai, S., Xi, X., Zhang, G., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.133317 · Cited by 13
Spermidine rejuvenates T lymphocytes and restores anticancer immunosurveillance in aged mice
Castoldi, F., Kroemer, G., & Pietrocola, F. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2146855 · Cited by 13
Pang, L., Feng, H., Zhong, W. H., Dong, H., Shen, Y., Yu, B., & Cong, H. (2021) · Materials & Design · doi:10.1016/j.matdes.2021.110159 · Cited by 12
Park, B. K., Kim, J. P., Baylink, D. J., Hino, C., Kwon, C., Tran, V., Xiao, J., Cao, H. L., Lee, S., Tan, L. D., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06606-z · Cited by 12
“Elevated potassium levels in the TME impair T cell effector function by limiting T-cell nutrient uptake; however, increased potassium can preserve T-cell stemness and long-term survival [96].”
A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade
Yi, W., Qian, X., Yan, D., Yan, W., Hu, S., Li, Y., & Wang, D. (2025) · Advanced Materials · doi:10.1002/adma.202504733 · Cited by 12
Yu, Q., Jiang, D., Zhao, T., Guan, Y., Zhang, J., Yang, D., Sun, R., Yu, W., Wang, Z., Chen, S., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.06.019 · Cited by 13
Resident Memory T Cells in the Tumor Microenvironment
Williams, J. B., & Kupper, T. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_3 · Cited by 12
Nanotechnology‐Assisted Immunoengineering for Cancer Vaccines
Mamuti, M., Chen, W., & Jiang, X. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200080 · Cited by 12
Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo
Palianina, D., Mietz, J., Stühler, C., Arnold, B., Bantug, G. R., Münz, C., Chijioke, O., & Khanna, N. (2024) · Science Advances · doi:10.1126/sciadv.ado2048 · Cited by 12
Immunometabolism Modulation in Therapy
Monferrer, E., Sanegre, S., Vieco-Martí, I., López-Carrasco, A., Fariñas, F., Villatoro, A. J., Abanades, S., Mañes, S., de la Cruz‐Merino, L., Noguera, R., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9070798 · Cited by 13
“In addition, elevated potassium levels within the TME have been recognized to disrupt T-cell nutrient uptake, leading to a stemness state, further limiting the acquisition of Teff metabolism [69].”
BackgroundWang, R., Wen, Z.-Y., Liu, F.-H., Wei, Y., Xu, H.-L., Sun, M., Zhao, Y., Gong, T., Wang, H., & Wu, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.891936 · Cited by 13
“As the precursors of bases, potassium (71), magnesium (72), and calcium (73) could inhibit the metastasis and the growth of cancer cells.”
BackgroundCellular Chemical Field and Cellular Homeostasis
Cong, B., Lü, L., Wang, Q., He, T., Li, J., Xie, H., Zhang, A., & Fan, X. (2024) · Engineering · doi:10.1016/j.eng.2024.03.001 · Cited by 11
High Extracellular K + Skews T‐Cell Differentiation Towards Tumour Promoting Th2 and T reg Subsets
Wong, B. H. S., Poh, Z. S., Wei, J. T. C., Amuthavalli, K., Ho, Y. S., Chen, S., Mak, S. Y., Bi, X., Webster, R. D., Shelat, V. G., et al. (2024) · European Journal of Immunology · doi:10.1002/eji.202451440 · Cited by 11
Yang, M., Zhang, W., Su, L., Chen, Q., Liu, W., Dai, M., & Ran, H. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161735 · Cited by 11
Quadruplexes with a grain of salt: influence of cation type and concentration on DNA G4 stability
Cucchiarini, A., Kledus, F., Luo, Y., Brázda, V., & Mergny, J. (2025) · European Biophysics Journal · doi:10.1007/s00249-025-01772-w · Cited by 11
“These channels in healthy cell lines maintain the correct balance of Na + /K + , where intracellular concentration of potassium is higher than extracellular (~ 145 mM and ~ 5 mM, respectively) (Vodnala et al. 2019).”
Zhang, C., Sun, Y., Li, S., Shen, L., Teng, X., Xiao, Y., Zhou, P., & Lu, Z. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1419 · Cited by 11
“We used a mCherryeGFP-LC3 fusion reporter system to evaluate autophagic flux in live PTCs.(10) GFP fluorescence is quenched upon fusion of the autophagosome with the acidified lysosome, whereas acidinsensitive mCherry fluorescence remains until this protein is degraded (Figure 1c).”
MethodInfluentialClaiborne, M. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1061411 · Cited by 11
“Extracellular potassium, increased in the TME as a consequence of cellular necrosis, serves to induce T cell metabolic programs that restrain acquisition of effector function via decreases in acetyl-CoAmediated epigenetic remodeling, yet also sustains expression of stemness markers such as Tcf7 (49, 50).”
BackgroundInfluentialWang, K., Ou, K., Zeng, Y., Yue, C., Zhuo, Y., Wang, L., Chen, H., & Tu, S. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104729 · Cited by 11
Guo, X., Feng, H., Xi, Z., Zhou, J., Huang, Z., Guo, J., Zheng, J., Lyu, Z., Liu, Y., Zhou, J., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011455 · Cited by 11
Chen, Z.-X., Xiao, F., Zhu, X., Zhou, W., Rui, K., Lu, L., & Tian, J. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156349 · Cited by 11
Ai, J., Du, Y., Xue, Q., Peng, W., & Zhou, Q. (2026) · International Journal of Biological Sciences · doi:10.7150/ijbs.125206 · Cited by 10
“It is crucial to utilize novel immunotherapies, such as adoptive transfer of TILs, CAR-T or TCR-T cell therapies [26, 95, 146], and inhibitors targeting immune checkpoints [147] and metabolic checkpoints [30].”
Pan, T., Shen, M., Shi, J., Ning, J., Su, F., Liao, J., & Tian, Y. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130450 · Cited by 10
CD8+ T cell metabolic changes in breast cancer
Castoldi, Â., Lee, J., Carvalho, D. D. S., & Souto, F. O. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166565 · Cited by 12
Chimeric antigen receptor T cells therapy in solid tumors
Rababah, F., Alabduh, T., Awawdeh, A., Shatnawi, T., AL-shdaifat, M., Ibdah, E., Shatnawi, S., AbuZetun, Y. I., Helaly, A. M., & Ghorab, D. S. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03122-8 · Cited by 10
“Increasing potassium levels in the tumor microenvironment affect nutrient uptake by T cells, which results in preserving T cell stemness and inhibits the differentiation of cells to effector phenotypes [127].”
BackgroundThe unfolding story of dying tumor cells during cancer treatment
He, S., Huang, Q., & Cheng, J. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1073561 · Cited by 11
Inorganic ion-sensitive imaging probes for biomedical applications
Wang, Q., Wang, P., Huang, C., Cui, S., Yang, S., Li, F., & Ling, D. (2023) · Chemical Communications · doi:10.1039/d3cc00418j · Cited by 10
Xia, J., Wang, C., & Li, B. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1451650 · Cited by 11
Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes
Zhang, C., Sun, Y., Li, S., Shen, L., Teng, X., Xiao, Y., Wu, N., & Lu, Z. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004868 · Cited by 10
Car-T Cell Therapy: Current Advances and Future Research Possibilities
Ahmed, M. M. E. (2021) · Journal of Scientific Research in Medical and Biological Sciences · doi:10.47631/jsrmbs.v2i2.234 · Cited by 18
Chen, W., Liu, W., Li, Y., Wang, J., Ren, Y., Wang, G., Chen, C., & Li, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.716042 · Cited by 10
Konz, T., Monnard, C., Rincón-Restrepo, M., Laval, J., Sizzano, F., Girotra, M., Dammone, G., Palini, A. G., Coukos, G., Rezzi, S., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05643 · Cited by 10
Sustained immune youth risks autoimmune disease in the aging host
Weyand, C. M., & Goronzy, J. J. (2025) · Nature Aging · doi:10.1038/s43587-025-00919-w · Cited by 9
“T cells with stem-like properties were originally described in the CD8 + compartment 57,58 .”
Tian, Z., Huang, Y., Wang, Y., Zhao, C., Zhou, Z., Yang, H., & Qiu, Y. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70083 · Cited by 9
Thangaraj, S. S., Thiesson, H. C., Svenningsen, P., Stubbe, J., Palarasah, Y., Bistrup, C., Jensen, B. L., & Mortensen, L. A. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00104.2021 · Cited by 9
Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications
Meymandi, A. R. P., Akbari, B., Soltantoyeh, T., Hadjati, J., Klionsky, D. J., Badie, B., & Mirzaei, H. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212695 · Cited by 10
“Moreover, autophagy activation in CD8+ T cells within the TME reduces T cell exhaustion and improves tumor control (69).”
BackgroundWang, B., Xiong, Y., Ren, L., Zhang, J., & Zhang, S. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1251 · Cited by 9
Developing innovative strategies of tumor‑infiltrating lymphocyte therapy for tumor treatment
Yu, Z., Shi, J., Fang, Y., Zhao, Y., Xu, A., & Li, N. (2024) · Oncology Reports · doi:10.3892/or.2024.8744 · Cited by 9
“An overabun‑ dance of extracellular potassium suppresses T‑cell effector functions by limiting nutrient uptake while improving the production of CD8 + T‑cells with enhanced in vivo persistence, stemness and tumor eradication ability (58).”
BackgroundSelf-citationMetal coordination polymer nanoparticles for cancer therapy
Zhang, Z., Rana, I., & Nam, J. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253012 · Cited by 10
Combination strategies to target metabolic flexibility in cancer
Krstić, J., Schindlmaier, K., & Prokesch, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.001 · Cited by 10
Singh, A., Choudhury, S. D., Singh, P., Singh, V. V., Singh, S. N., & Sharma, A. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04507-y · Cited by 9
Bian, W., Wang, Q., Cui, H., Tao, P., Zheng, J., Zhang, Y., Li, J., Li, F., Jia, H., & Ling, D. (2025) · Advanced Science · doi:10.1002/advs.202417678 · Cited by 8
Therapeutic application of nanosystems-based metalloptosis for enhanced tumor radiotherapy
Chen, M., Chen, L., Mao, K., Shi, Y.-B., Sun, M., Zhou, Y., Li, Z., & Luo, G. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216666 · Cited by 9
Wang, M., Komanduri, K. V., Datta, D., Patel, A. R., Whitaker, B. I., Belov, A. A., Rubin, B., Vashist, R., Rodríguez-Monguió, R., Cinar, P., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025016375 · Cited by 9
“40-52 The treatment centers were treated as a random effect covariate, accounting for the variabilities of patient populations and clinical care at each center.”
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
Coukos, G., Donia, M., Gastman, B., Goff, S. L., Gros, A., Harari, A., Hernandez, S., Ito, F., Maker, A. V., Mullinax, J. E., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013420 · Cited by 8
Self-citationLi, A. W., Briones, J. D., Lü, J., Walker, Q., Martinez, R., Hiraragi, H., Boldajipour, B. A., Sundar, P. D., Potluri, S., Lee, G., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-72392-1 · Cited by 11
Logic‐Gated Proximity Aptasensing for Cell‐Surface Real‐Time Monitoring of Apoptosis
Zheng, J., Wang, Q., Shi, L., Peng, P., Shi, L., & Li, T. (2021) · Angewandte Chemie · doi:10.1002/ange.202106651 · Cited by 8
Liu, Y., Yuan, Y., Chen, T., Xiao, H., Zhang, X., & Zhang, F. (2023) · Aging · doi:10.18632/aging.205221 · Cited by 8
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Good, M. L., Vizcardo, R., Maeda, T., Tamaoki, N., Malekzadeh, P., Kawamoto, H., & Restifo, N. P. (2019) · Journal of Visualized Experiments · doi:10.3791/59997 · Cited by 8
Self-citationHernández‐Oliveras, A., & Zarain‐Herzberg, Á. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00655-x · Cited by 8
Reprogramming T cell stemness against cancer
Wang, J., Yan, R., Jia, D., & Chen, S. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.09.004 · Cited by 7
Dutta, G., Mishra, P., Mishra, S. P., & Badhai, J. (2026) · Onco · doi:10.3390/onco6030031 · Cited by 7
“Chronic nutrient excess and inflammatory signaling can reprogram the metabolism of CD8+ T cells and NK cells, reducing mitochondrial fitness, proliferative capacity, cytokine production, and cytotoxic activity [102,103].”
Flati, I., Nolfi, M. D. V., Dall’Aglio, F., Vecchiotti, D., Verzella, D., Alesse, E., Capece, D., & Zazzeroni, F. (2023) · Genes · doi:10.3390/genes14101953 · Cited by 8
Puttalingaiah, R. T., Dean, M. J., Zheng, L., Philbrook, P., Wyczechowska, D. D., Kayes, T., Valle, L. D., Danos, D., & Sanchez‐Pino, M. D. (2024) · Cells · doi:10.3390/cells13201736 · Cited by 7
“However, in solid tumors, necrotic cells release their intracellular content into the extracellular space, where K + concentrations exceed 40 mM [2].”
BackgroundMethodResultInfluentialDynamic Nanostructure‐Based DNA Logic Gates for Cancer Diagnosis and Therapy
Bi, S., Yang, R., Ju, H., & Liu, Y. (2024) · ChemBioChem · doi:10.1002/cbic.202400754 · Cited by 8
Metal-modulated T cell antitumor immunity and emerging metalloimmunotherapy
Liao, P., Zhou, Y., Qiu, Y., Hu, R., Li, H., Sun, H., & Li, Y. (2025) · Cancer and Metastasis Reviews · doi:10.1007/s10555-025-10266-2 · Cited by 7
“Tumor-bearing mice exhibit prolonged survival when infused with T cells cultured in high-K + medium [182].”
InfluentialDNA-Based Fluorescent Nanoprobe for Cancer Cell Membrane Imaging
Wu, X., Shuai, X., Nie, K., Li, J. Y., Liu, L., Wang, L., Huang, C. Z., & Li, C. M. (2024) · Molecules · doi:10.3390/molecules29010267 · Cited by 7
“…tumor cells release up to 50 mM of K + into the extracellular space, thereby inhibiting the Akt-mTOR pathway and the activity of T-cell effector molecules, thus affecting their killing effect on T-cells, which causes cancer cells to escape the immune system and proliferate uncontrollably [51,52].”
BackgroundJiang, Q., Chen, L., Chen, H., Tang, Z., Liu, F., & Sun, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.739509 · Cited by 8
PERK/ATF3-Reduced ER Stress on high potassium environment in the suppression of tumor ferroptosis
Pu, X., Li, L., Chen, Z., Gong, A., Lei, J., Zhang, L., & Tsai, H. (2023) · Journal of Cancer · doi:10.7150/jca.83556 · Cited by 7
“Previous research also disclosed that high extracellular K+ levels may influence mitochondrial metabolism [30].”
Li, G., Wu, Q., Mou, Y., Qiao, Y., Jin, L., Shi, Q., Zhang, R., Li, J., Sun, Y., Zhang, A., et al. (2025) · Theranostics · doi:10.7150/thno.112612 · Cited by 6
“Additionally, autophagy is also closely related to the processing of MHC-presented antigens, and induction of autophagy generates CD8+ T cells with tumor-scavenging capacity [25, 36].”
Metadata
- Authors
- Vodnala, S. K., Eil, R., Kishton, R. J., Sukumar, M., Yamamoto, T. N., Ha, N.-H., Lee, P.-H., Shin, M., Patel, S. J., Yu, Z., Palmer, D. C., Kruhlak, M. J., Liu, X., Locasale, J. W., Huang, J., Roychoudhuri, R., Finkel, T., Klebanoff, C. A., & Restifo, N. P.
- Affiliations
- National Institutes of Health (US)
- National Cancer Institute (US)
- Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.
- Duke University (US)
- Babraham Institute (GB)
- University of Pittsburgh (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Vodnala, Suman Kumar
- Eil, Robert
- Restifo, Nicholas P.
- ORCID
- Vodnala, Suman Kumar
- Eil, Robert
- Kishton, Rigel J.
- Sukumar, Madhusudhanan
- Yamamoto, Tori N.
- Ha, Ngoc-Han
- Lee, Ping-Hsien
- Shin, MinHwa
- Patel, Shashank J.
- Yu, Zhiya
- Palmer, Douglas C.
- Kruhlak, Michael J.
- Liu, Xiaojing
- Locasale, Jason W.
- Huang, Jing
- Roychoudhuri, Rahul
- Finkel, Toren
- Klebanoff, Christopher A.
- Restifo, Nicholas P.
- Venue
- Science
- Published
- 2019-03-29
- Volume
- 363
- Issue
- 6434
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC8194369
- OpenAlex
- W2924300946
- Cited by
- 552
- References
- 49
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 78 · 2023: 70 · 2022: 86 · 2021: 76 · 2020: 73 · 2019: 36
- FWCI
- 27.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Cancer Society (129832-RSG-16-214-01-TBE)
- National Cancer Institute (P30 CA008748)
- NIH Clinical Center
- Damon Runyon Cancer Research Foundation
- Parker Institute for Cancer Immunotherapy
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- T cell stemness, T cell dysfunction, tumor microenvironment, potassium ions, T cell metabolism, nutrient uptake, autophagy, acetyl-CoA, T cell exhaustion, antitumor immunity, tumor immune evasion
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Animals, Autophagy, Cell Differentiation, Histones, Humans, Immune Tolerance, Lymphocyte Activation, Mice, Inbred C57BL, Neoplasms, Potassium, Stem Cells, Lymphocytes, Tumor-Infiltrating, CD8-Positive T-Lymphocytes, Caloric Restriction, Epigenesis, Genetic, Mice, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.